Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia

Clinical trial NCT07714070 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07714070
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Neoplasms Endometrial Cancer Atypical Endometrial Hyperplasia Progestin Resistance

Start date: 2026-07-01
Primary completion: 2027-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.